Cells 2012, 1(4), 961-975; doi:10.3390/cells1040961

Cell and Gene Therapy Approaches for Cardiac Vascularization

Received: 13 September 2012; in revised form: 16 October 2012 / Accepted: 25 October 2012 / Published: 5 November 2012
(This article belongs to the Special Issue Tissue and Organ Regeneration)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Despite encouraging preclinical results for therapeutic angiogenesis in ischemia, a suitable approach providing sustained, safe and efficacious vascular growth in the heart is still lacking. Vascular Endothelial Growth Factor (VEGF) is the master regulator of angiogenesis, but it also can easily induce aberrant and dysfunctional vascular growth if its expression is not tightly controlled. Control of the released level in the microenvironment around each cell in vivo and its distribution in tissue are critical to induce stable and functional vessels for therapeutic angiogenesis. The present review discusses the limitations and perspectives of VEGF gene therapy and of different cell-based approaches for the implementation of therapeutic angiogenesis in the treatment of cardiac ischemia.
Keywords: angiogenesis; VEGF controlled release; cell therapy; gene therapy; cell-based gene therapy; cardiac tissue engineering; cardiac ischemia
PDF Full-text Download PDF Full-Text [220 KB, uploaded 5 November 2012 16:27 CET]

Export to BibTeX |

MDPI and ACS Style

Melly, L.; Boccardo, S.; Eckstein, F.; Banfi, A.; Marsano, A. Cell and Gene Therapy Approaches for Cardiac Vascularization. Cells 2012, 1, 961-975.

AMA Style

Melly L, Boccardo S, Eckstein F, Banfi A, Marsano A. Cell and Gene Therapy Approaches for Cardiac Vascularization. Cells. 2012; 1(4):961-975.

Chicago/Turabian Style

Melly, Ludovic; Boccardo, Stefano; Eckstein, Friedrich; Banfi, Andrea; Marsano, Anna. 2012. "Cell and Gene Therapy Approaches for Cardiac Vascularization." Cells 1, no. 4: 961-975.

Cells EISSN 2073-4409 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert